IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omega Fund Management, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 13 holdings | $311.9K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2019-05-20) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Gossamer Bio(GOSS)ACommon Stock38341P102$150.7K6,953,41648.3%
Replimune(REPL)Common Stock76029N106$77.4K5,103,45524.8%
Translate BioCommon Stock89374L104$24.8K2,437,6038.0%
Paratek PharmaceuticalsCommon Stock699374302$13.9K2,600,4104.5%
ObsEvaCommon StockH5861P103$12.8K999,3644.1%
CymaBay Therapeutics(CBAYUSD)Common Stock23257D103$7.3K551,4772.3%
FibroGen(FGENEUR)Common Stock31572Q808$7.1K130,6462.3%
Cidara TherapeuticsCommon Stock171757107$4.0K1,508,7941.3%
Essa Pharma(EPIEUR)Common Stock29668H708$3.7K1,084,8481.2%
Jounce Therapeutics(JNCEEUR)Common Stock481116101$3.3K529,9651.1%
Pieris PharmaceuticalsCommon Stock720795103$2.6K778,2300.8%
Dicerna Pharmaceuticals(DRNAUSD)Common Stock253031108$2.4K167,1570.8%
Sienna Biopharmaceuticals(SNNAQ)Common Stock82622H108$1.8K758,6100.6%